Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

Transplantation

Volumn 73, Issue 9, 2002, Pages 1386-1391

  Millan, Maria T ^a   Shizuru, Judith A ^a   Hoffmann, Petra ^a   Dejbakhsh Jones, Sussan ^a   Scandling, John D ^a   Grumet, F Carl ^a   Tan, Jane C ^a   Salvatierra, Oscar ^a   Hoppe, Richard T ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CELL LINEAGE; CHIMERA; DONOR; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; LYMPH NODE IRRADIATION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; PRIORITY JOURNAL; RECIPIENT; STEM CELL MOBILIZATION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION TOLERANCE;

EID: 0037093290     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200205150-00005     Document Type: Article

References (25)

1. Tolerance, mixed chimerism and protection against GVHD after TLI
2. Mixed chimerism
3. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys
4. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohernatopoietic chimerism
5. The effects of chimeric cells following donor bone marrow infusions and detected by PCR-flow assays in kidney transplant recipients
6. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients
7. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia
8. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
9. Transplant-Lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
10. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
11. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation
12. Transplantation of allogeneic bone marrow without graft vs. host disease using total lymphoid irradiation
13. Engraftment of allogeneic bone marrow without graft vs. host disease in mongrel dogs using total lymphoid irradiation
14. + T Cells in mice conditioned with fractionated lymphoid irradiation protects against graft versus host disease
15. Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection
16. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers
17. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: Studies of chimerism and anti-donor reactivity
18. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma
19. Clonable progenitors committed to the T lymphocyte lineage in the mouse bone marrow: Use of an extrathymic pathway
20. Comparison of chimeric and non-chimeric tolerance using posttransplant TLI: Cytokine expression and chronic rejection
21. Cyclosporine facilitates chimeric and inhibits non-chimeric tolerance after posttransplant total lymphoid irradiation (TLI)
22. Acquired immune tolerance to cadaveric renal allografts
23. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
24. Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses
25. Clinical and immunological studies of cadaveric renal transplant recipients given total lymphoid irradiation (TLI) and maintained on low dose prednisone